簡介

本頁面提供了有關 Thomas Gad 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Thomas Gad已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:YMAB / Y-mAbs Therapeutics, Inc. CHIEF BUSINESS OFFICER, Director 0
如何解讀這些圖表

以下圖表顯示了在Thomas Gad進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Thomas Gad 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2025-09-18 2025-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
U - Other -60,000 0 -100.00 8.60 -516,000
2025-09-18 2025-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
U - Other -67,681 0 -100.00 8.60 -582,057
2025-09-18 2025-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
D - Sale to Issuer -60,235 0 -100.00
2025-09-18 2025-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
U - Other -245,486 0 -100.00 8.60 -2,111,180
2025-06-05 2025-06-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 103,000 305,721 50.81 2.00 206,000 611,442
2025-03-11 2025-03-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -10,810 202,721 -5.06 5.23 -56,536 1,060,231
2025-01-22 2025-01-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
A - Award 32,000 213,531 17.63
2024-09-20 2024-09-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 22,831 181,531 14.39 4.38 100,000 795,106
2024-09-17 2024-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -30,000 67,681 -30.71 12.97 -389,100 877,823
2024-09-17 2024-09-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -65,000 97,681 -39.96 13.47 -875,550 1,315,763
2024-06-11 2024-06-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -35,000 162,681 -17.71 12.00 -420,000 1,952,172
2024-06-11 2024-06-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -35,000 197,681 -15.04 12.03 -421,050 2,378,102
2024-05-23 2024-05-23 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -7,351 232,681 -3.06 13.00 -95,563 3,024,853
2024-05-23 2024-05-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -25,000 240,032 -9.43 12.00 -300,000 2,880,384
2024-03-07 2024-03-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -3,900 158,700 -2.40 16.44 -64,116 2,609,028
2024-01-22 2024-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
A - Award 22,100 162,600 15.73
2023-12-26 2023-12-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 50,000 140,500 55.25 2.00 100,000 281,000
2023-12-15 2023-12-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 265,032 -15.87 6.61 -330,500 1,751,862
2023-12-15 2023-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 315,032 -13.70 6.83 -341,500 2,151,669
2023-12-15 2023-12-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 365,032 -12.05 6.58 -329,000 2,401,911
2023-11-22 2023-11-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -75,000 415,032 -15.31 5.31 -397,988 2,202,367
2023-11-22 2023-11-20 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -75,000 490,032 -13.27 5.30 -397,395 2,596,484
2023-01-19 2023-01-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
A - Award 40,500 90,500 81.00
2022-05-19 2022-05-18 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 60,000 60,000
2022-02-09 2022-02-09 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -64,276 565,032 -10.21 6.96 -447,117 3,930,476
2022-02-09 2022-02-08 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -125,863 629,308 -16.67 7.01 -882,891 4,414,407
2022-02-09 2022-02-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -91,031 755,171 -10.76 7.59 -691,180 5,733,862
2022-02-07 2022-02-04 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -101,104 846,202 -10.67 7.70 -778,531 6,516,009
2022-02-07 2022-02-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -35,060 947,306 -3.57 7.90 -277,027 7,485,138
2022-02-03 2022-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -8,000 153,000 -4.97
2022-02-03 2022-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -8,000 50,000 -13.79 10.15 -81,161 507,255
2022-02-03 2022-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 8,000 58,000 16.00 2.00 16,000 116,000
2022-01-26 2022-01-24 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -55,783 982,366 -5.37 10.96 -611,281 10,764,963
2022-01-26 2022-01-24 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -32,272 1,038,149 -3.01 10.07 -325,131 10,459,040
2022-01-24 2022-01-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -20,184 1,070,421 -1.85 11.35 -229,103 12,150,028
2022-01-24 2022-01-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,134 1,090,605 -4.39 10.51 -526,713 11,458,005
2022-01-24 2022-01-20 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -112,767 1,140,739 -9.00 11.33 -1,277,289 12,920,923
2022-01-20 2022-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -69,414 1,253,506 -5.25 10.89 -756,092 13,653,814
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -8,000 161,000 -4.73
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -400 1,322,920 -0.03 11.46 -4,584 15,160,663
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -8,000 50,000 -13.79 11.54 -92,314 576,965
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 8,000 58,000 16.00 2.00 16,000 116,000
2021-12-16 2021-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 110,000 110,000
2021-12-16 2021-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
G - Gift 60,000 1,383,320 4.53
2021-12-16 2021-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
G - Gift -60,000 1,323,320 -4.34
2021-12-08 2021-12-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -10,000 1,383,320 -0.72 17.58 -175,832 24,323,192
2021-12-08 2021-12-06 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -4,000 1,393,320 -0.29 16.50 -65,982 22,983,510
2021-12-08 2021-12-06 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -40,000 1,397,320 -2.78 16.48 -659,260 23,029,930
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,437,320 -0.28 16.98 -67,912 24,402,963
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -7,770 1,441,320 -0.54 17.04 -132,433 24,566,002
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -12,800 1,449,090 -0.88 17.11 -218,947 24,786,974
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -600 1,461,890 -0.04 16.94 -10,166 24,769,241
2021-12-01 2021-11-29 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -22,437 1,462,490 -1.51 17.16 -385,026 25,096,767
2021-11-26 2021-11-23 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -50,000 169,000 -22.83
2021-11-26 2021-11-23 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 50,000 -50.00 17.06 -852,850 852,850
2021-11-26 2021-11-23 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 50,000 100,000 100.00 2.00 100,000 200,000
2021-11-18 2021-11-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,484,927 -0.27 19.33 -77,302 28,696,957
2021-11-01 2021-10-29 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,488,927 -0.27 24.82 -99,261 36,948,021
2021-10-19 2021-10-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,492,927 -0.27 27.20 -108,799 40,607,316
2021-10-04 2021-09-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,496,927 -0.27 28.26 -113,054 42,308,546
2021-09-17 2021-09-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,500,927 -0.27 33.64 -134,579 50,498,239
2021-09-07 2021-09-07 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -50,000 219,000 -18.59
2021-09-07 2021-09-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 50,000 50,000 2.00 100,000 100,000
2021-09-07 2021-09-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 1,504,927 -3.22 33.18 -1,658,915 49,930,919
2021-08-17 2021-08-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -1,779 1,554,927 -0.11 28.96 -51,527 45,036,906
2021-08-17 2021-08-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -22,111 1,556,706 -1.40 29.33 -648,527 45,658,965
2021-08-17 2021-08-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,578,817 -0.25 29.14 -116,544 46,000,412
2021-08-17 2021-08-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -1,110 1,582,817 -0.07 31.01 -34,426 49,089,645
2021-08-05 2021-08-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,583,927 -0.25 33.73 -134,927 53,428,709
2021-07-21 2021-07-20 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,587,927 -0.25 32.47 -129,875 51,558,084
2021-07-08 2021-07-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,591,927 -0.25 31.87 -127,465 50,728,664
2021-07-02 2021-06-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,595,927 -0.25 33.86 -135,446 54,040,323
2021-06-15 2021-06-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,599,927 -0.25 35.80 -143,217 57,284,266
2021-06-01 2021-05-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,603,927 -0.25 36.95 -147,813 59,270,396
2021-05-20 2021-05-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,607,927 -0.25 34.07 -136,290 54,785,932
2021-04-28 2021-04-26 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 269,000 -2.54
2021-04-28 2021-04-26 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 27.96 -195,730
2021-04-28 2021-04-26 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 276,000 -2.47
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,611,927 -0.25 26.60 -106,388 42,872,422
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 26.61 -186,253
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -9,000 283,000 -3.08
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -6,000 1,615,927 -0.37 30.27 -181,615 48,912,818
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -9,000 0 -100.00 30.26 -272,331
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 9,000 9,000 2.00 18,000 18,000
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 292,000 -2.34
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,621,927 -0.25 36.78 -147,102 59,647,176
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 36.79 -257,554
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-03-12 2021-03-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
J - Other 1,029,927 1,625,927 172.81
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -9,000 299,000 -2.92
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -6,000 596,000 -1.00 35.50 -213,029 21,160,861
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -9,000 0 -100.00 35.51 -319,611
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 9,000 9,000 2.00 18,000 18,000
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 308,000 -2.22
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 602,000 -0.66 47.09 -188,367 28,349,203
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 47.08 -329,556
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 315,000 -2.17
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 606,000 -0.66 41.97 -167,888 25,435,032
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 41.99 -293,897
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 322,000 -2.13
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 610,000 -0.65 46.56 -186,230 28,400,136
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 46.51 -325,563
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 329,000 -2.08
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 614,000 -0.65 49.31 -197,248 30,277,568
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 49.36 -345,509
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2020-12-30 2020-12-28 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 336,000 -2.04
2020-12-30 2020-12-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 51.98 -363,833
2020-12-30 2020-12-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2020-12-17 2020-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 343,000 -2.00
2020-12-17 2020-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 53.01 -371,065
2020-12-17 2020-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2020-12-16 2020-12-14 4 VYMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 618,000 -0.64 52.89 -211,546 32,683,795
2020-12-16 2020-12-15 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 91,450 91,450
2020-12-14 2020-12-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 0 -100.00 51.17 -2,558,640
2020-12-14 2020-12-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 50,000 50,000 2.00 100,000 100,000
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -50,000 350,000 -12.50
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -50,000 350,000 -12.50
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 0 -100.00 50.75 -2,537,620
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 50,000 50,000 2.00 100,000 100,000
2020-12-02 2020-12-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 622,000 -0.64 51.42 -205,685 31,984,049
2020-11-17 2020-11-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 626,000 -0.63 46.17 -184,672 28,901,105
2020-11-05 2020-11-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 630,000 -0.63 43.69 -174,769 27,526,086
2020-10-19 2020-10-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 634,000 -0.63 39.15 -156,604 24,821,671
2020-10-02 2020-10-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 638,000 -0.62 38.88 -155,524 24,806,142
2020-09-17 2020-09-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 642,000 -0.62 40.81 -163,225 26,197,580
2020-09-15 2020-09-14 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -22,569 450,000 -4.78
2020-09-15 2020-09-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -22,569 0 -100.00 41.00 -925,426
2020-09-15 2020-09-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 22,569 22,569 2.00 45,138 45,138
2020-09-15 2020-09-11 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -13,571 472,569 -2.79
2020-09-15 2020-09-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -13,571 0 -100.00 40.33 -547,331
2020-09-15 2020-09-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 13,571 13,571 2.00 27,142 27,142
2020-09-15 2020-09-10 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -13,860 486,140 -2.77
2020-09-15 2020-09-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -13,860 0 -100.00 41.58 -576,360
2020-09-15 2020-09-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 13,860 13,860 2.00 27,720 27,720
2020-09-02 2020-09-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 646,000 -0.62 41.60 -166,390 26,872,050
2020-08-19 2020-08-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 650,000 -0.61 40.35 -161,392 26,226,200
2020-08-13 2020-08-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -13,000 654,000 -1.95 39.51 -513,636 25,839,867
2020-08-13 2020-08-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -37,000 667,000 -5.26 40.06 -1,482,042 26,716,818
2020-08-05 2020-08-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 704,000 -0.56 36.51 -146,026 25,700,576
2020-07-17 2020-07-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 708,000 -0.56 40.06 -160,229 28,360,568
2020-07-06 2020-07-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 712,000 -0.56 42.04 -168,178 29,935,684
2020-06-16 2020-06-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 716,000 -0.56 43.45 -173,811 31,112,205
2020-06-05 2020-06-04 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 720,000 -0.55 41.61 -166,444 29,959,848
2020-05-29 2020-05-27 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 724,000 -6.46 39.01 -1,950,460 28,242,661
2020-05-20 2020-05-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 774,000 -0.51 39.65 -158,596 30,688,326
2020-05-14 2020-05-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 778,000 -6.04 39.04 -1,951,935 30,372,109
2020-05-05 2020-05-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 828,000 -0.48 32.35 -129,404 26,786,711
2020-04-15 2020-04-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 832,000 -0.48 29.43 -117,711 24,483,930
2020-03-18 2020-03-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 836,000 -0.48 18.01 -72,041 15,056,527
2020-03-04 2020-03-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 840,000 -0.47 29.18 -116,713 24,509,772
2020-02-20 2020-02-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 844,000 -0.47 32.78 -131,133 27,669,021
2020-02-11 2020-02-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 848,000 -0.47 33.03 -132,121 28,009,610
2020-01-29 2020-01-27 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 852,000 -0.47 35.06 -140,224 29,867,627
2020-01-15 2020-01-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 856,000 -0.47 30.90 -123,612 26,452,968
2020-01-09 2020-01-07 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 130,000 130,000
2019-12-31 2019-12-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
J - Other -201 1,030,356 -0.02
2019-12-17 2019-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 860,000 -0.46 31.54 -126,176 27,127,926
2019-12-17 2019-12-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
G - Gift -8,000 864,000 -0.92
2019-12-04 2019-12-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 872,000 -0.46 32.48 -129,930 28,324,827
2019-11-19 2019-11-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 876,000 -0.45 28.41 -113,658 24,891,014
2019-11-05 2019-11-04 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 880,000 -0.45 30.10 -120,418 26,491,960
2019-10-22 2019-10-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 884,000 -0.45 27.59 -110,351 24,387,527
2019-10-08 2019-10-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 888,000 -0.45 25.21 -100,848 22,388,256
2019-09-17 2019-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 892,000 -0.45 30.59 -122,376 27,289,759
2019-09-05 2019-09-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 896,000 -0.44 25.77 -103,081 23,090,099
2019-08-20 2019-08-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 900,000 -0.44 27.70 -110,805 24,931,080
2019-08-06 2019-08-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 904,000 -0.44 21.78 -87,106 19,685,866
2019-07-23 2019-07-22 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 908,000 -0.44 22.54 -90,177 20,470,134
2019-07-10 2019-07-08 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 912,000 -0.44 22.40 -89,592 20,426,885
2019-06-25 2019-06-24 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 916,000 -0.43 21.77 -87,098 19,945,350
2019-06-11 2019-06-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 920,000 -0.43 22.79 -91,166 20,968,272
2019-06-04 2019-06-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 924,000 -0.43 20.03 -80,121 18,507,997
2019-05-29 2019-05-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -6,000 928,000 -0.64 20.21 -121,252 18,753,674
2019-05-14 2019-05-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -6,000 934,000 -0.64 20.61 -123,647 19,247,779
2019-04-11 2019-04-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -150,000 940,000 -13.76 25.80 -3,870,000 24,252,000
2019-04-11 2019-04-09 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -800 1,090,000 -0.07 26.93 -21,545 29,355,444
2019-04-11 2019-04-09 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -99,200 1,090,800 -8.34 26.02 -2,581,184 28,382,616
2018-12-13 2018-12-11 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 107,500 107,500
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
3,410,557
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
3,251,114
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
3,410,557
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
3,251,114
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
3,410,557
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
3,251,114
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)